Publicação

Single hepatocytes show persistence and transcriptional inactivity of hepatitis B

Ver documento

Detalhes bibliográficos
Resumo:There is no cure for the more than 270 million people chronically infected with HBV. Nucleos(t)ide analogs (NUCs), the mainstay of anti-HBV treatment, block HBV reverse transcription. NUCs do not eliminate the intranuclear covalently closed circular DNA (cccDNA), from which viral RNAs, including pregenomic RNA (pgRNA), are transcribed. A key gap in designing a cure is understanding how NUCs affect HBV replication and transcription because serum markers yield an incomplete view of intrahepatic HBV. We applied single-cell laser capture microdissection and droplet digital PCR to paired liver biopsies collected from 5 HBV/HIV-coinfected persons who took NUCs over 2-4 years. From biopsy 1 to 2, proportions of HBV-infected hepatocytes declined with adherence to NUC treatment (P < 0.05); we extrapolated that eradication of HBV will take over 10 decades with NUCs in these participants. In individual hepatocytes, pgRNA levels diminished 28- to 73-fold during NUC treatment, corresponding with decreased tissue HBV core antigen staining (P < 0.01). In 4 out of 5 participants, hepatocytes with cccDNA but undetectable pgRNA (transcriptionally inactive) were present, and these were enriched in 3 participants during NUC treatment. Further work to unravel mechanisms of cccDNA transcriptional inactivation may lead to therapies that can achieve this in all hepatocytes, resulting in a functional cure.
Autores principais:Balagopal, Ashwin
Outros Autores:Grudda, Tanner; Ribeiro, Ruy; Saad, Yasmeen S.; Hwang, Hyon S.; Quinn, Jeffrey; Murphy, Michael; Ward, Kathleen; Sterling, Richard K.; Zhang, Yang; Perelson, Alan S.; Sulkowski, Mark S.; Osburn, William O.; Thio, Chloe L.
Assunto:Hepatitis Hepatology Infectious disease Molecular biology
Ano:2020
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
_version_ 1866810329447530496
author Balagopal, Ashwin
author2 Grudda, Tanner
Ribeiro, Ruy
Saad, Yasmeen S.
Hwang, Hyon S.
Quinn, Jeffrey
Murphy, Michael
Ward, Kathleen
Sterling, Richard K.
Zhang, Yang
Perelson, Alan S.
Sulkowski, Mark S.
Osburn, William O.
Thio, Chloe L.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Balagopal, Ashwin
Grudda, Tanner
Ribeiro, Ruy
Saad, Yasmeen S.
Hwang, Hyon S.
Quinn, Jeffrey
Murphy, Michael
Ward, Kathleen
Sterling, Richard K.
Zhang, Yang
Perelson, Alan S.
Sulkowski, Mark S.
Osburn, William O.
Thio, Chloe L.
author_role author
contributor_name_str_mv Repositório Científico de Acesso Aberto da ULisboa
country_str PT
creators_json_txt [{\"Person.name\":\"Balagopal, Ashwin\"},{\"Person.name\":\"Grudda, Tanner\"},{\"Person.name\":\"Ribeiro, Ruy\",\"Person.identifier.orcid\":\"0000-0002-3988-8241\"},{\"Person.name\":\"Saad, Yasmeen S.\"},{\"Person.name\":\"Hwang, Hyon S.\"},{\"Person.name\":\"Quinn, Jeffrey\"},{\"Person.name\":\"Murphy, Michael\"},{\"Person.name\":\"Ward, Kathleen\"},{\"Person.name\":\"Sterling, Richard K.\"},{\"Person.name\":\"Zhang, Yang\"},{\"Person.name\":\"Perelson, Alan S.\"},{\"Person.name\":\"Sulkowski, Mark S.\"},{\"Person.name\":\"Osburn, William O.\"},{\"Person.name\":\"Thio, Chloe L.\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
datacite.creators.creator.creatorName.fl_str_mv Balagopal, Ashwin
Grudda, Tanner
Ribeiro, Ruy
Saad, Yasmeen S.
Hwang, Hyon S.
Quinn, Jeffrey
Murphy, Michael
Ward, Kathleen
Sterling, Richard K.
Zhang, Yang
Perelson, Alan S.
Sulkowski, Mark S.
Osburn, William O.
Thio, Chloe L.
datacite.date.Accepted.fl_str_mv 2020-01-01T00:00:00Z
datacite.date.available.fl_str_mv 2020-12-02T13:16:28Z
datacite.date.embargoed.fl_str_mv 2020-12-02T13:16:28Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Hepatitis
Hepatology
Infectious disease
Molecular biology
datacite.titles.title.fl_str_mv Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
dc.contributor.none.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
dc.creator.none.fl_str_mv Balagopal, Ashwin
Grudda, Tanner
Ribeiro, Ruy
Saad, Yasmeen S.
Hwang, Hyon S.
Quinn, Jeffrey
Murphy, Michael
Ward, Kathleen
Sterling, Richard K.
Zhang, Yang
Perelson, Alan S.
Sulkowski, Mark S.
Osburn, William O.
Thio, Chloe L.
dc.date.Accepted.fl_str_mv 2020-01-01T00:00:00Z
dc.date.available.fl_str_mv 2020-12-02T13:16:28Z
dc.date.embargoed.fl_str_mv 2020-12-02T13:16:28Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10451/45062
dc.language.none.fl_str_mv eng
dc.publisher.none.fl_str_mv American Society for Clinical Investigation
dc.rights.cclincense.fl_str_mv http://creativecommons.org/licenses/by/4.0/
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Hepatitis
Hepatology
Infectious disease
Molecular biology
dc.title.fl_str_mv Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description There is no cure for the more than 270 million people chronically infected with HBV. Nucleos(t)ide analogs (NUCs), the mainstay of anti-HBV treatment, block HBV reverse transcription. NUCs do not eliminate the intranuclear covalently closed circular DNA (cccDNA), from which viral RNAs, including pregenomic RNA (pgRNA), are transcribed. A key gap in designing a cure is understanding how NUCs affect HBV replication and transcription because serum markers yield an incomplete view of intrahepatic HBV. We applied single-cell laser capture microdissection and droplet digital PCR to paired liver biopsies collected from 5 HBV/HIV-coinfected persons who took NUCs over 2-4 years. From biopsy 1 to 2, proportions of HBV-infected hepatocytes declined with adherence to NUC treatment (P < 0.05); we extrapolated that eradication of HBV will take over 10 decades with NUCs in these participants. In individual hepatocytes, pgRNA levels diminished 28- to 73-fold during NUC treatment, corresponding with decreased tissue HBV core antigen staining (P < 0.01). In 4 out of 5 participants, hepatocytes with cccDNA but undetectable pgRNA (transcriptionally inactive) were present, and these were enriched in 3 participants during NUC treatment. Further work to unravel mechanisms of cccDNA transcriptional inactivation may lead to therapies that can achieve this in all hepatocytes, resulting in a functional cure.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://repositorio.ulisboa.pt/bitstreams/8adc2692-aad6-444a-a828-457db6080464/download
id ul_915fdcbfd2a2a4e57041d8f79e8ce1e9
identifier.url.fl_str_mv http://hdl.handle.net/10451/45062
instacron_str ul
institution Universidade de Lisboa
instname_str Universidade de Lisboa
language eng
network_acronym_str ul
network_name_str Repositório da Universidade de Lisboa
oai_identifier_str oai:repositorio.ulisboa.pt:10451/45062
organization_str_mv urn:organizationAcronym:ul
person_str_mv Balagopal, Ashwin
Grudda, Tanner
Ribeiro, Ruy
Ribeiro, Ruy
https://www.ciencia-id.pt/9A15-E40B-738F
9A15-E40B-738F
http://orcid.org/0000-0002-3988-8241
0000-0002-3988-8241
Saad, Yasmeen S.
Hwang, Hyon S.
Quinn, Jeffrey
Murphy, Michael
Ward, Kathleen
Sterling, Richard K.
Zhang, Yang
Perelson, Alan S.
Sulkowski, Mark S.
Osburn, William O.
Thio, Chloe L.
publishDate 2020
publisher.none.fl_str_mv American Society for Clinical Investigation
reponame_str Repositório da Universidade de Lisboa
repository_id_str urn:repositoryAcronym:ul
service_str_mv urn:repositoryAcronym:ul
spelling engAmerican Society for Clinical Investigationpt_PTThere is no cure for the more than 270 million people chronically infected with HBV. Nucleos(t)ide analogs (NUCs), the mainstay of anti-HBV treatment, block HBV reverse transcription. NUCs do not eliminate the intranuclear covalently closed circular DNA (cccDNA), from which viral RNAs, including pregenomic RNA (pgRNA), are transcribed. A key gap in designing a cure is understanding how NUCs affect HBV replication and transcription because serum markers yield an incomplete view of intrahepatic HBV. We applied single-cell laser capture microdissection and droplet digital PCR to paired liver biopsies collected from 5 HBV/HIV-coinfected persons who took NUCs over 2-4 years. From biopsy 1 to 2, proportions of HBV-infected hepatocytes declined with adherence to NUC treatment (P < 0.05); we extrapolated that eradication of HBV will take over 10 decades with NUCs in these participants. In individual hepatocytes, pgRNA levels diminished 28- to 73-fold during NUC treatment, corresponding with decreased tissue HBV core antigen staining (P < 0.01). In 4 out of 5 participants, hepatocytes with cccDNA but undetectable pgRNA (transcriptionally inactive) were present, and these were enriched in 3 participants during NUC treatment. Further work to unravel mechanisms of cccDNA transcriptional inactivation may lead to therapies that can achieve this in all hepatocytes, resulting in a functional cure.application/pdfpt_PTSingle hepatocytes show persistence and transcriptional inactivity of hepatitis BBalagopal, AshwinGrudda, TannerPersonalRibeiro, RuyDSpacehttp://dspace.org/items/215b5cf4-faab-41ea-becf-c63bed56d3d1DSpacehttp://dspace.org/items/215b5cf4-faab-41ea-becf-c63bed56d3d1RibeiroRuy MiguelCiência IDhttps://www.ciencia-id.pt9A15-E40B-738FORCIDhttp://orcid.org0000-0002-3988-8241Saad, Yasmeen S.Hwang, Hyon S.Quinn, JeffreyMurphy, MichaelWard, KathleenSterling, Richard K.Zhang, YangPerelson, Alan S.Sulkowski, Mark S.Osburn, William O.Thio, Chloe L.HostingInstitutionOrganizationalRepositório Científico de Acesso Aberto da ULisboae-mailmailto:repositorio@reitoria.ulisboa.ptrepositorio@reitoria.ulisboa.ptDOIIsPartOf10.1172/jci.insight.1405842020-12-02T13:16:28Z20202020-01-01T00:00:00ZHandlehttp://hdl.handle.net/10451/45062http://purl.org/coar/access_right/c_abf2open accessHepatitisHepatologyInfectious diseaseMolecular biology4078158 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal article2020http://creativecommons.org/licenses/by/4.0/http://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://repositorio.ulisboa.pt/bitstreams/8adc2692-aad6-444a-a828-457db6080464/downloadJCI Insight519
spellingShingle Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
Balagopal, Ashwin
Hepatitis
Hepatology
Infectious disease
Molecular biology
status SINGLETON
subject.fl_str_mv Hepatitis
Hepatology
Infectious disease
Molecular biology
title Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
title_full Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
title_fullStr Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
title_full_unstemmed Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
title_short Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
title_sort Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
topic Hepatitis
Hepatology
Infectious disease
Molecular biology
topic_facet Hepatitis
Hepatology
Infectious disease
Molecular biology
url http://hdl.handle.net/10451/45062
visible 1